Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma

Journal of Immunology

Volumn 185, Issue 9, 2010, Pages 5586-5597

  Munroe, Melissa E ^a   Businga, Thomas R ^b   Kline, Joel N ^b   Bishop, Gail A ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; COLLAGEN; CYTOKINE; HONOKIOL; INTERLEUKIN 6; METHACHOLINE; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; BIPHENYL DERIVATIVE; LIGNAN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOBLAST; B LYMPHOCYTE; CELL COUNT; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHILIA; FEMALE; GOBLET CELL; HOMOGENATE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SENSITIZATION; SYMPTOM; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; ASTHMA; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HYPERSENSITIVITY; IMMUNOLOGY; LUNG; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BIPHENYL COMPOUNDS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HYPERSENSITIVITY; LIGNANS; LUNG; MICE; MICE, INBRED C57BL; TH2 CELLS;

EID: 78149491659     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000630     Document Type: Article

References (63)

1. Busse, W. W., and R. F. Lemanske, Jr. 2001. Asthma. N. Engl. J. Med. 344:350-362.
2. Chanez, P., S. E. Wenzel, G. P. Anderson, J. M. Anto, E. H. Bel, L. P. Boulet, C. E. Brightling, W. W. Busse, M. Castro, B. Dahlen, et al. 2007. Severe asthma in adults: what are the important questions? J. Allergy Clin. Immunol. 119:1337-1348.
3. Akdis, M., and C. A. Akdis. 2009. Therapeutic manipulation of immune tolerance in allergic disease. Nat. Rev. Drug Discov. 8:645-660.
4. Nakajima, H., and K. Takatsu. 2007. Role of cytokines in allergic airway inflammation. Int. Arch. Allergy Immunol. 142:265-273.
5. Randolph, D. A., R. Stephens, C. J. Carruthers, and D. D. Chaplin. 1999. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J. Clin. Invest. 104:1021-1029.
6. McKinley, L., J. F. Alcorn, A. Peterson, R. B. Dupont, S. Kapadia, A. Logar, A. Henry, C. G. Irvin, J. D. Piganelli, A. Ray, and J. K. Kolls. 2008. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181:4089-4097.
7. Russo, C., and R. Polosa. 2005. TNF-α as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clin. Sci. 109:135-142.
8. Rose-John, S., G. H. Waetzig, J. Scheller, J. Grötzinger, and D. Seegert. 2007. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin. Ther. Targets 11:613-624.
9. Fonseca, D. E., and J. N. Kline. 2009. Use of CpG oligonucleotides in treatment of asthma and allergic disease. Adv. Drug Deliv. Rev. 61:256-262.
10. Munroe, M. E., J. L. Arbiser, and G. A. Bishop. 2007. Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J. Immunol. 179:753-763.
11. Son, H. J., H. J. Lee, H. S. Yun-Choi, and J. H. Ryu. 2000. Inhibitors of nitric oxide synthesis and TNF-α expression from Magnolia obovata in activated macrophages. Planta Med. 66:469-471.
12. Liou, K. T., Y. C. Shen, C. F. Chen, C. M. Tsao, and S. K. Tsai. 2003. The antiinflammatory effect of Honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur. J. Pharmacol. 475:19-27.
13. A receptors: properties and trafficking. Crit. Rev. Biochem. Mol. Biol. 42:3-14.
14. Tian, J., Y. Lu, H. Zhang, C. H. Chau, H. N. Dang, and D. L. Kaufman. 2004. γ-Aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J. Immunol. 173:5298-5304.
15. Alam, S., D. L. Laughton, A. Walding, and A. J. Wolstenholme. 2005. Human peripheral blood mononuclear cells express GABAA receptor subunits. Mol. Immunol. 43:1432-1442.
16. A agonist muscimol attenuates induced airway constriction in guinea pigs in vivo. J. Appl. Physiol. 106:1257-1263.
17. Durairaj, L., J. Launspach, J. L. Watt, T. R. Businga, J. N. Kline, P. S. Thorne, and J. Zabner. 2004. Safety assessment of inhaled xylitol in mice and healthy volunteers. Respir. Res. 5:13.
18. Khelef, N., C. M. Bachelet, B. B. Vargaftig, and N. Guiso. 1994. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect. Immun. 62:2893-2900.
19. Mookerjee, I., N. R. Solly, S. G. Royce, G. W. Tregear, C. S. Samuel, and M. L. Tang. 2006. Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease. Endocrinology 147:754-761.
20. Bolender, R. P., D. M. Hyde, and R. T. Dehoff. 1993. Lung morphometry: a new generation of tools and experiments for organ, tissue, cell, and molecular biology. Am. J. Physiol. 265: L521-L548.
21. Ogami, A., Y. Morimoto, H. Yamato, T. Oyabu, T. Kajiwara, and I. Tanaka. 2004. Patterns of histopathological change determined by the point counting method and its application for the hazard assessment of respirable dust. Inhal. Toxicol. 16:793-800.
22. Brown, S., M. Worsfold, and C. Sharp. 2001. Microplate assay for the measurement of hydroxyproline in acid-hydrolyzed tissue samples. Biotechniques 30:38-40, 42.
23. Keane, M. P., J. A. Belperio, T. A. Moore, B. B. Moore, D. A. Arenberg, R. E. Smith, M. D. Burdick, S. L. Kunkel, and R. M. Strieter. 1999. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162:5511-5518.
24. Waldschmidt, T. J., A. Panoskaltsis-Mortari, R. T. McElmurry, L. T. Tygrett, P. A. Taylor, and B. R. Blazar. 2002. Abnormal T cell-dependent B-cell responses in SCID mice receiving allogeneic bone marrow in utero: severe combined immune deficiency. Blood 100:4557-4564.
25. Lewkowich, I. P., J. D. Rempel, and K. T. HayGlass. 2004. Antigen-specific versus total immunoglobulin synthesis: total IgE and IgG1, but not IgG2a levels predict murine antigen-specific responses. Int. Arch. Allergy Immunol. 133:145-153.
26. Munroe, M. E., and G. A. Bishop. 2007. A costimulatory function for T cell CD40. J. Immunol. 178:671-682.
27. Bishop, G. A., W. D. Warren, and M. T. Berton. 1995. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Eur. J. Immunol. 25:1230-1238.
28. Baccam, M., S. Y. Woo, C. Vinson, and G. A. Bishop. 2003. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kB, AP-1, and C/EBP. J. Immunol. 170:3099-3108.
29. Henderson, W. R., Jr., G. K. Chiang, Y. T. Tien, and E. Y. Chi. 2006. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am. J. Respir. Crit. Care Med. 173:718-728.
30. Amano, T., J. Nishihira, and I. Miki. 2007. Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation. Inflamm. Res. 56:24-31.
31. Afshar, R., B. D. Medoff, and A. D. Luster. 2008. Allergic asthma: a tale of many T cells. Clin. Exp. Allergy 38:1847-1857.
32. Chen, G. Y., C. Chen, L. Wang, X. Chang, P. Zheng, and Y. Liu. 2008. Cutting edge: broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. J. Immunol. 180:5163-5166.
33. +CD252 T cells. J. Clin. Invest. 112:1437-1443.
34. Hur, G. Y., D. H. Koh, H. A. Kim, H. J. Park, Y. M. Ye, K. S. Kim, and H. S. Park. 2008. Prevalence of work-related symptoms and serum-specific antibodies to wheat flour in exposed workers in the bakery industry. Respir. Med. 102:548-555.
35. Rieckmann, P., J. M. Tuscano, and J. H. Kehrl. 1997. Tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) in B-lymphocyte function. Methods 11:128-132.
36. Babu, K. S., D. E. Davies, and S. T. Holgate. 2004. Role of tumor necrosis factor a in asthma. Immunol. Allergy Clin. North Am. 24:583-597, v-vi.
37. Doganci, A., K. Sauer, R. Karwot, and S. Finotto. 2005. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin. Rev. Allergy Immunol. 28:257-270.
38. Brown, K. D., B. S. Hostager, and G. A. Bishop. 2001. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J. Exp. Med. 193:943-954.
39. Tian, J., C. Chau, T. G. Hales, and D. L. Kaufman. 1999. GABAA receptors mediate inhibition of T cell responses. J. Neuroimmunol. 96:21-28.
40. Lee, A. K., S. H. Sung, Y. C. Kim, and S. G. Kim. 2003. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-a and COX-2 expression by sauchinone effects on I-kBa phosphorylation, C/EBP and AP-1 activation. Br. J. Pharmacol. 139:11-20.
41. Bjurstöm, H., J. Wang, I. Ericsson, M. Bengtsson, Y. Liu, S. Kumar-Mendu, S. Issazadeh-Navikas, and B. Birnir. 2008. GABA, a natural immunomodulator of T lymphocytes. J. Neuroimmunol. 205:44-50.
42. Gruenberg, D., and W. Busse. 2010. Biologic therapies for asthma. Curr. Opin. Pulm. Med. 16:19-24.
43. Chen, F., T. Wang, Y. F. Wu, Y. Gu, X. L. Xu, S. Zheng, and X. Hu. 2004. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J. Gastroenterol. 10:3459-3463.
44. Berry, M. A., B. Hargadon, M. Shelley, D. Parker, D. E. Shaw, R. H. Green, P. Bradding, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord. 2006. Evidence of a role of tumor necrosis factor a in refractory asthma. N. Engl. J. Med. 354:697-708.
45. + Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 115:313-325.
46. Qiu, Z., M. Fujimura, K. Kurashima, S. Nakao, and N. Mukaida. 2004. Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen. Clin. Exp. Allergy 34:1321-1328.
47. Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N. Pagé, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108:430-438.
48. Chen, Y., P. Thai, Y. H. Zhao, Y. S. Ho, M. M. DeSouza, and R. Wu. 2003. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278:17036-17043.
49. Wakashin, H., K. Hirose, Y. Maezawa, S. Kagami, A. Suto, N. Watanabe, Y. Saito, M. Hatano, T. Tokuhisa, Y. Iwakura, et al. 2008. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 178:1023-1032.
50. Hutchison, S., B. S. Choo-Kang, R. V. Bundick, A. J. Leishman, J. M. Brewer, I. B. McInnes, and P. Garside. 2008. Tumour necrosis factor-a blockade suppresses murine allergic airways inflammation. Clin. Exp. Immunol. 151:114-122.
51. Stämpfli, M. R., M. Cwiartka, B. U. Gajewska, D. Alvarez, S. A. Ritz, M. D. Inman, Z. Xing, and M. Jordana. 1999. Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. Am. J. Respir. Cell Mol. Biol. 21:586-596.
52. Moore, B., R. F. Murphy, and D. K. Agrawal. 2008. Interaction of tgf-b with immune cells in airway disease. Curr. Mol. Med. 8:427-436.
53. Matsumoto, K., H. Inoue, M. Tsuda, Y. Honda, A. Kibe, K. Machida, Y. Yoshiura, and Y. Nakanishi. 2005. Different roles of interleukin-10 in onset and resolution of asthmatic responses in allergen-challenged mice. Respirology 10:18-26.
54. Akbari, O., P. Stock, R. H. DeKruyff, and D. T. Umetsu. 2003. Role of regulatory T cells in allergy and asthma. Curr. Opin. Immunol. 15:627-633.
55. + T helper cells engineered to produce latent TGF-b1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105:61-70.
56. Meiler, F., J. Zumkehr, S. Klunker, B. Rückert, C. A. Akdis, and M. Akdis. 2008. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 205:2887-2898.
57. + regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J. Allergy Clin. Immunol. 122:617-624, e6.
58. Shu, W., H. Yang, L. Zhang, M. M. Lu, and E. E. Morrisey. 2001. Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J. Biol. Chem. 276:27488-27497.
59. Kalinichenko, V. V., L. Lim, B. Shin, and R. H. Costa. 2001. Differential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L695-L704.
60. Ai, J., X. Wang, and M. Nielsen. 2001. Honokiol and magnolol selectively interact with GABAA receptor subtypes in vitro. Pharmacology 63:34-41.
61. A receptors are expressed and facilitate relaxation in airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L1206-L1216.
62. A channels on airway smooth muscle potentiates isoproterenol-mediated relaxation. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L1040-L1047.
63. Bai, X., F. Cerimele, M. Ushio-Fukai, M. Waqas, P. M. Campbell, B. Govindarajan, C. J. Der, T. Battle, D. A. Frank, K. Ye, et al. 2003. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J. Biol. Chem. 278:35501-35507.